Comparison of oncology drug approval between Health Canada and the US Food and Drug Administration

E-ISSN： 1097-0142|121|10|1688-1693

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.10, 2015-05, pp. : 1688-1693

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Primary human papillomavirus screening for cervical cancer in the United States—US Food and Drug Administration approval, clinical trials, and where we are today

CANCER CYTOPATHOLOGY, Vol. 122, Iss. 10, 2014-10 ,pp. : 720-729

John Wiley & Sons Inc

Access to resources Recommend Favorite

Under‐representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993‐2013

CANCER, Vol. 120, Iss. 19, 2014-10 ,pp. : 3025-3032

John Wiley & Sons Inc

Access to resources Recommend Favorite

Generic drug approval: A US perspective

By Nagori B.P. Mathur V. Garg S.

Current Medical Research and Opinion, Vol. 27, Iss. 3, 2011-03 ,pp. : 541-545

Informa Healthcare

Access to resources Recommend Favorite

Glioblastoma survival in the United States improved after Food and Drug Administration approval of bevacizumab: A population‐based analysis

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3489-3495

John Wiley & Sons Inc

Access to resources Recommend Favorite

Safety assessment of niacin in the US Food and Drug Administration's mini‐sentinel system

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, Vol. 27, Iss. 1, 2018-01 ,pp. : 30-37

John Wiley & Sons Inc

Access to resources Recommend Favorite